1. Home
  2. NNDM vs RGNX Comparison

NNDM vs RGNX Comparison

Compare NNDM & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.91

Market Cap

401.4M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.35

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
RGNX
Founded
2012
2008
Country
United States
United States
Employees
468
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.4M
418.1M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
NNDM
RGNX
Price
$1.91
$9.35
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
1.8M
501.4K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
$102,437,000.00
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
N/A
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
77.30
126.48
52 Week Low
$1.31
$6.89
52 Week High
$2.32
$16.19

Technical Indicators

Market Signals
Indicator
NNDM
RGNX
Relative Strength Index (RSI) 60.22 56.09
Support Level $1.47 $7.68
Resistance Level $2.11 $9.41
Average True Range (ATR) 0.09 0.47
MACD 0.01 0.02
Stochastic Oscillator 83.87 78.95

Price Performance

Historical Comparison
NNDM
RGNX

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: